Seminars in Arthritis and Rheumatism

Papers
(The H4-Index of Seminars in Arthritis and Rheumatism is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis102
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study93
Response letter to the editor83
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review60
mRNA vaccines in the rheumatologist's future56
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder56
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes54
Response to the correspondence by Xu et al. regarding "Toward a more actionable RA-ILD risk model"47
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial45
Metabolomics in systemic lupus erythematosus: A systematic review and meta-analysis45
Immunotherapy in cancer43
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]43
Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features42
Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival42
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort41
Exploring the association between adiposity, pain intensity, and effusion-synovitis in people with knee osteoarthritis: A cross-sectional study40
Correspondence to ‘Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors’40
Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts40
A clue for subclinical CNO in adolescents with acne conglobata and hidradenitis suppurativa: Persistan acute phase rectans elevation38
Refining RA-ILD screening: Diagnostic limitations and the emerging role of lung ultrasound37
HIF-1α in Gout: A central regulator of metabolism, inflammation, and environmental stress36
Systemic sclerosis-related digital ulcers: Current understanding and updated management approaches- a primer for clinicians36
Evaluation of disease severity and treatment responses in patients with enthesitis-related arthritis35
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments34
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment34
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors33
Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances33
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis33
Incidence of malignancy in systemic sclerosis: A systematic review and meta-analysis33
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance32
The Autoantibody response in rheumatoid arthritis; what makes it unique?32
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?32
0.22359395027161